Home › Funds › Citigroup Inc › SGMT
Citigroup Inc position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Latest position (Q2 2026)52.84K sh
Reported value held$408.44K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 858 | $4.65K | New |
| Q1 2024 | 5.01K | $27.15K | Add |
| Q2 2024 | 135.74K | $464.24K | Add |
| Q3 2024 | 116.73K | $323.34K | Reduce |
| Q4 2024 | 111.21K | $500.44K | Reduce |
| Q2 2025 | 3.63K | $27.67K | New |
| Q4 2025 | 17.98K | $106.42K | New |
| Q1 2026 | 13.59K | $70.99K | Reduce |
| Q2 2026 | 52.84K | $408.44K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SGMT
- BlackRock Inc 6.58M sh · $50.83M · Q2 2026
- Balyasny Asset Management 3.63M sh · $28.03M · Q2 2026
- Geode Capital Management 1.44M sh · $11.17M · Q2 2026
- Vanguard Group 1.26M sh · $7.46M · Q4 2025
- Millennium Management 937.02K sh · $7.24M · Q2 2026
- Goldman Sachs Group 759.09K sh · $5.87M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Northern Trust Corp 468.38K sh · $3.62M · Q2 2026
- Farallon Capital Management 415.00K sh · $3.21M · Q2 2026
- Renaissance Technologies 346.93K sh · $2.68M · Q2 2026
- UBS Group AG 339.93K sh · $2.63M · Q2 2026
- Citadel Advisors 289.93K sh · $2.24M · Q2 2026